Medinotec (MDNC) Common Equity (2022 - 2026)

Medinotec (MDNC) has reported Common Equity for 5 consecutive years, with $5.9 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Common Equity rose 33.96% year-over-year to $5.9 million; the trailing twelve-month figure through May 2026 stood at $5.9 million (up 33.96% YoY), and the FY2026 full-year result was $5.7 million, up 33.73% from the prior year.
• Common Equity rose to $5.9 million in Q2 2026 per MDNC's latest filing, from $5.7 million in the prior quarter.
• Across five years, Common Equity topped out at $5.9 million in Q2 2026 and bottomed at -$469985.0 in Q1 2022.
• Historically, Common Equity has averaged $3.2 million across 5 years, with a median of $2.7 million in 2022.
• The widest YoY moves for Common Equity: up 643.86% in 2023, down 29.52% in 2023.
• Over 5 years, Common Equity stood at $2.9 million in 2022, then dropped by 29.52% to $2.1 million in 2023, then jumped by 36.17% to $2.8 million in 2024, then jumped by 94.64% to $5.5 million in 2025, then grew by 6.4% to $5.9 million in 2026.
• According to Business Quant data, Common Equity over the past three periods registered $5.9 million, $5.7 million, and $5.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.